Clinical trial
Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are…
NCT00022373 · National Cancer Institute (NCI), NIH · Unknown status
Key facts
| NCT number | NCT00022373 |
|---|---|
| Title | Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer |
| Official title | A Multinational, Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase III Clinical Trial to Determine the Efficacy and Safety of IB-367 Rinse in Reducing the Severity of Oral Mucositis in Patients Receiving Radiotherapy for Head and Neck Malignancy |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer, Oral Complications of Radiation Therapy, Radiation Toxicity |
| Intervention type | Drug, Procedure |
| Interventions | iseganan HCl oral solution, management of therapy complications |
| Start date | Dec 1, 2000 |
| First posted | Feb 4, 2004 |
| Last update posted | Oct 15, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: